2m 2m 2m 2m 2m 2m 2m
INOVIO PHARMA (INO)
NASDAQ
$0.70+$0.02 (+2.95%)
Price as of Aug 03, 2026 5:21 PM EDT- $55.7MMarket Cap
- -52.66%1-Year Change
- BiotechnologyIndustry
INOVIO PHARMA (INO)
$0.70+$0.02 (+2.95%)
INO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.68 | ||
Change | +$0.02 (+3.20%) | ||
Open | $0.65 | ||
High | $0.68 | ||
Low | $0.62 | ||
Previous Close | $0.66 | ||
Volume | 12,679,989 | ||
30-Day Average Volume | 3,555,870 | ||
1-Week Change | -30.21% | ||
1-Month Change | -38.45% | ||
1-Year Change | -52.66% | ||
3-Year Change | -89.40% | ||
5-Year Change | -99.33% | ||
Fundamentals | |||
Shares Outstanding | 82.3M | ||
Total Assets | $49.8M | ||
Market Cap | $55.7M | ||
Enterprise Value | $29.4M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$19.7M | ||
Free Cash Flow | -$21.6M | ||
EBIT | -$19.7M | ||
EBITDA | -$19.4M | ||
Net Working Capital | $1.5M | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 9 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/25/2024 | ||
Earnings & Revenue